Spago Nanomedical conducts research and development in cancer diagnostics. The company conducts various development projects based on its proprietary nanomaterials whose potential is found in making tumours visible, and enabling internal radiation therapy of cancer. The company was founded in 2007 and is based in Lund.

Quotes for Spago Nanomedical AB

Right Now

+/-
-0.04
%
-0,58%
Latest
6.86
High
7.2
Low
6.84
Volume
61 161
Turnover (SEK)
428 379
Value (MSEK)
216,4

Board

CEO

  • Mats Hansen

Chairman Of The Board

  • Eugen Steiner

Board

  • Kari Grønås
  • Nicklas Westerholm
  • Peter Leander
  • Sten Nilsson

Videos

Largest Owners

Name Capital % Votes % Date
Peter Lindell 18,08 18,08 2020-03-31
HealthInvest Partners 8,10 8,10 2020-06-30
Eva Redhe 7,14 7,14 2020-03-31
Avanza Pension 6,50 6,50 2020-03-31
Mikael Lönn 6,28 6,28 2020-03-31
Andreas Bunge med närstående 4,56 4,56 2020-03-31
Thord Wilkne 4,39 4,39 2020-03-31
Ranny Davidoff 4,38 4,38 2020-03-31
Tiel Ridderstad 4,36 4,36 2020-03-31
Claes Dahlbäck 2,42 2,42 2020-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream